John Ugelstad building
The John Ugelstad building is the fourth section of Oslo Cancer Cluster Innovation Park and opened 27 November 2025.

Oslo Cancer Cluster Innovation Park has expanded with a fourth section, on the west side of the existing building.
The new section is 12,000 square meters and includes offices and laboratories for cancer researchers from academia and private companies, as well as a joint employee restaurant and meeting room centre.
Tenants include:
- Thermo Fisher Scientific, leasing 2 floors of laboratories and 2 floors of offices for research and development in cell and gene therapies
- The Advanced Cell Therapy (ACT) Centre from the Institute of Cancer Research
- The non-profit organisation Active Against Cancer, offering training facilities for cancer patients
- The non-profit organisation Youth Cancer is sponsoring a youth room for young people affected by cancer

John Ugelstad
John Ugelstad (31 March 1921 – 3 April 1997) was a Norwegian chemical engineer and inventor, known for discovering a process to manufacture monodisperse micropellets, also known of dynabeads. This invention was later commercialised by a Norwegian biotech company, Dynal Biotech Group, and ultimately acquired by Thermo Fisher Scientific. Dynabeads are today used, among other things, in billions of diagnostic tests and in the development and production of life-saving cancer treatments, such as CAR T therapies.




Oversikt ferdig bygg
Bygget er ferdigstilt og åpnet offisielt 27.11.2025. En samlet helhet vises på tegningene under.